Announcements Trials
Browse Landscape

Status

Completed 5Unknown 1Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2NETWORK 1

Study Type

Interventional 274Observational 7Expanded_access 1

Sponsor

Cancer Type

Lymphoid 7Other hematologic neoplasm 3

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 3Recurrence 2Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma 1Hodgkin Disease 1

Interventions

Rituximab 29Surveys and Questionnaires 25Blood Specimen Collection 17Gene Expression Profiling 15Flow Cytometry 14Polymerase Chain Reaction 13Amplified Fragment Length Polymorphism Analysis 13Microarray Analysis 11Observation 10Interviews as Topic 10Psychiatric Rehabilitation 9Lenalidomide 9Immunohistochemistry 9Cytogenetic Analysis 9obinutuzumab 8Watchful Waiting 8Therapeutics 8ibrutinib 7Drug Therapy 7Cyclophosphamide 7Bendamustine Hydrochloride 7Vincristine 6Prednisone 6Magnetic Resonance Spectroscopy 6fludarabine 5In Situ Hybridization, Fluorescence 5Immunologic Techniques 5Data Collection 5Biopsy 5zanubrutinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Observational × Bendamustine Hydrochloride × Lymphoid × Clear all
NCT07145125 2025-11-21

HL-R2-B2

University Hospital, Bordeaux

Completed
222 enrolled
Lymphoid

Hodgkin Disease, Recurrence

NCT05899621 2023-06-12

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

Ruijin Hospital

Recruiting
332 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT02491398 2020-10-06

LLC1315

Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed
494 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT04127916 2020-03-18

Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL)

Samsung Medical Center

Unknown
40 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT02381899 2019-02-01

Observational Study in CLL Patients Receiving BR

Czech CLL Study Group

Completed
83 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT02110394 2016-07-06

NORMA

Astellas Pharma Inc

Completed
190 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT02072967 2016-02-22

Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma

Astellas Pharma Inc

Completed
97 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡